Vanda Pharmaceuticals Stock
Vanda Pharmaceuticals Stock
Vanda Pharmaceuticals gained 1.960% today.
Our community is currently high on Vanda Pharmaceuticals with 4 Buy predictions and 0 Sell predictions.
However, we have a potential of -3.85% for Vanda Pharmaceuticals as the target price of 5 € is below the current price of 5.2 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vanda Pharmaceuticals stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vanda Pharmaceuticals in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vanda Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals | 1.960% | 14.350% | 14.350% | -10.526% | 31.443% | -62.774% | - |
| Ardelyx Inc. | -2.090% | 44.059% | 24.632% | 107.002% | 49.343% | 55.532% | - |
| Evolus Inc | -1.640% | 14.019% | 1.667% | 60.526% | 34.807% | 65.986% | - |
| Salarius Pharmaceuticals Inc. | -4.230% | 3.398% | -0.930% | -70.417% | -23.243% | -98.252% | -99.993% |
Comments
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for VNDA provided by MarketBeat